Abstract Background Human pegivirus 1 (HPgV-1) is a Positive-sense single-stranded RNA
(+ ssRNA) virus, discovered in 1995 as a Flaviviridae member, and the closest human virus …

The SARS‐CoV‐2 virus outbreak revealed that these nano‐pathogens have the ability to
rapidly change lives. Undoubtedly, SARS‐CoV‐2 as well as other viruses can cause …

An essential step in the entrance of enveloped viruses such as coronaviruses, the human
immunodeficiency virus, and influenza is membrane fusion. A unique class of glycoprotein …

The effective use of fusion inhibitor peptides against cervical and colorectal infections
requires the development of sustained release formulations. In this work we comparatively …

Based on the structure of an HIV-1 entry inhibitor peptide two stapled-and a retro-enantio
peptides have been designed to provide novel prevention interventions against HIV …

Peptides exhibit significant specificity and effective interaction with therapeutic targets,
positioning themselves as key players in the global pharmaceutical market. They offer …

In a previous work, we defined a novel HIV-1 fusion inhibitor peptide (E1P47) with a broad
spectrum of activity against viruses from different clades, subtypes, and tropisms. With the …

Compared with single-target drugs, multitarget drugs may improve the safety and efficacy of
the treatment of multifactorial diseases. However, few multitarget drugs are on the market or …

Co‐infection with the human pegivirus 1 (HPgV‐1) often has a beneficial effect on disease
progression in HIV‐1‐infected individuals. Several HPgV‐1 proteins and peptides, including …

Пептиды относятся к биологически активным веществам различного спектра действия.
Проведены исследования физико-химических свойств пепсинового гидролизата …